Clark Hayes Archives

Press ESC key to close search

HSBC Provides $20MM Term Loan to Click Therapeutics

Click Therapeutics, a provider of digital therapeutics as prescription medical treatments, closed on a $20 million term loan from HSBC Innovation Banking, a division of HSBC Bank USA. The term loan was partially drawn at closing, with the proceeds used to retire Click’s previous term loan.

Silicon Valley Bank Provides $15MM Debt Financing to Click Therapeutics

Click Therapeutics secured a $15 million term loan from Silicon Valley Bank and used proceeds from the financing in part to retire its existing term loan facility with K2 HealthVentures.

April 18, 2022 Clark Hayes | Click Therapeutics | Randall Stanicky | Silicon Valley Bank Ian Koplin

Silicon Valley Bank Provides $25MM Credit Facility to Eyenovia

Eyenovia, a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print therapeutics, entered into a new $25 million credit financing facility with Silicon Valley Bank.

May 11, 2021 Clark Hayes | Eyenovia | Sean Ianchuley | Silicon Valley Bank Ian Koplin

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Clark Hayes

HSBC Provides $20MM Term Loan to Click Therapeutics

Silicon Valley Bank Provides $15MM Debt Financing to Click Therapeutics

Silicon Valley Bank Provides $25MM Credit Facility to Eyenovia